Albireo Pharma logo
Albireo Pharma ALBO

Quarterly report 2022-Q3
added 11-08-2022

report update icon

Albireo Pharma Total Current Liabilities 2011-2026 | ALBO

Annual Total Current Liabilities Albireo Pharma

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
45.3 M 25.3 M 18.9 M 12.8 M 7.93 M 12.7 M 1.81 M 1.62 M 2.44 M 2.78 M 3.29 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
45.3 M 1.62 M 12.3 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer Total Current Liabilities Price % 24h Market Cap Country
Acer Therapeutics Acer Therapeutics
ACER
19 M - 2.71 % $ 14 M usaUSA
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
72.8 M - -15.15 % $ 60.3 M britainBritain
Adverum Biotechnologies Adverum Biotechnologies
ADVM
22.9 M - - $ 86.2 M usaUSA
ANI Pharmaceuticals ANI Pharmaceuticals
ANIP
194 M $ 80.34 - $ 1.55 B usaUSA
Acasti Pharma Acasti Pharma
ACST
1.93 M - 4.01 % $ 150 M canadaCanada
Aptorum Group Limited Aptorum Group Limited
APM
4.34 M $ 0.84 1.96 % $ 4.58 M chinaChina
I-Mab I-Mab
IMAB
576 M - - $ 866 M chinaChina
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
25.2 M - - $ 26.5 M usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.62 B - - $ 40.3 B usaUSA
Adagene Adagene
ADAG
38.2 M $ 2.67 - $ 150 M chinaChina
AlloVir AlloVir
ALVR
5.24 M - 4.14 % $ 49.1 M usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.77 M - -1.52 % $ 24.7 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
2.38 M - -11.43 % $ 502 K usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
15.1 M - - $ 10.1 M usaUSA
ARCA biopharma ARCA biopharma
ABIO
13 M - 1052.0 % $ 415 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
228 M - -24.86 % $ 820 K usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
39.8 M - - $ 3.67 B usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
54.1 M - - $ 1.01 B usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
99.9 M $ 1.5 - $ 281 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
4.46 M - -45.71 % $ 1.2 M canadaCanada
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
556 M - - - russiaRussia
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
15.7 M - 3.16 % $ 1.9 M usaUSA
Aptinyx Aptinyx
APTX
6.29 M - -39.0 % $ 4.57 M usaUSA
Aravive Aravive
ARAV
22.1 M - -13.39 % $ 1.45 M usaUSA
Cabaletta Bio Cabaletta Bio
CABA
16 M $ 2.44 - $ 2.85 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
66.3 M - -6.81 % $ 3.04 B usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
36.9 M - 17.91 % $ 11.1 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
5.91 M - -10.17 % $ 12.2 K usaUSA
Athira Pharma Athira Pharma
ATHA
13.1 M - - $ 269 M usaUSA
Athersys Athersys
ATHX
29.9 M - 3.77 % $ 22.4 M usaUSA
Akouos Akouos
AKUS
16.8 M - 0.23 % $ 488 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
816 K - -52.27 % $ 4.45 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
2.05 M $ 4.22 - $ 9.18 B israelIsrael
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
60.7 M $ 1.46 - $ 373 M britainBritain
Compugen Ltd. Compugen Ltd.
CGEN
20.2 M $ 1.71 - $ 153 M israelIsrael
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
1.13 B $ 14.52 - $ 4.49 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
3.78 M - 1.93 % $ 17.4 M usaUSA
AVROBIO AVROBIO
AVRO
6.35 M - 1083.1 % $ 745 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
58 M - - $ 2.17 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.54 M - - $ 7.46 M israelIsrael